<img alt="" src="https://secure.inventiveperception365.com/789096.png" style="display:none;">

Rapid Micro Biosystems Announces New Chief Financial Officer

POSTED BY Admin User | 3 minute read

Bedford, MA - (May 19, 2011) – Rapid Micro Biosystems, a leading provider of non-destructive, rapid microbial detection, today named Michael J. Mullen Chief Financial Officer. Mullen will lead the financial planning, accounting, human resources, supply chain and IT functions for the business.  He will report directly to the CEO, Steve Delity.

Mr. Mullen brings more than 30 years experience managing the financial endeavors in biotechnology and pharmaceutical instrument businesses.  Prior to his role as Chief Financial Officer for Rapid Micro Biosystems, Mullen was an interim CFO with Valeritas, Inc. and CFO with Magellan Biosciences.  While serving as CFO at Magellan Biosciences he implemented a comprehensive program of strategic acquisitions and divestitures which drove significant improvements in revenue and EBITDA.  

Mullen was a co-founder and partner at JMH Capital, and has also held senior financial management roles with PerkinElmer, Inc, and Thermo Optek. Mullen graduated from James Madison University in Harrisonburg, VA, with a BBA in accountancy.

“We are excited to have Michael join our executive team,” said CEO Steve Delity.  “His experience and knowledge in the pharmaceutical and biotech industry combined with his expertise in growing businesses will be integral to Rapid Micro Biosystems long-term objectives.”

Mullen commented:  “I am privileged to join Rapid Micro Biosystems at an inflection point in the company’s history. I am impressed with the business’ performance thus far and am eager to play a role in the company’s plans forward.”

About Rapid Micro Biosystems

Rapid Micro Biosystems, headquartered in Bedford, Massachusetts, provides innovative products for faster detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. The Company’s Growth Direct™ System detects contamination earlier, delivering compelling economic benefits to manufacturers while improving their quality process. The Growth Direct™ System is the first and only automated system that accelerates testing, fits with current regulatory practices, and addresses all key applications. For more information, visit www.rapidmicrobio.com.


Mark Severns
Rapid Micro Biosystems